Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Outlook Therapeutics Inc (NASDAQ: OTLK) closed the day trading at $0.89 down -0.20% from the previous closing price of $0.89. In other words, the price has decreased by -$0.20 from its previous closing price. On the day, 3.62 million shares were traded. OTLK stock price reached its highest trading level at $0.915 during the session, while it also had its lowest trading level at $0.8194.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 26 ’24 when KENYON LAWRENCE A bought 5,000 shares for $5.69 per share. The transaction valued at 28,446 led to the insider holds 5,946 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OTLK now has a Market Capitalization of 39453400 and an Enterprise Value of 65250316. For the stock, the TTM Price-to-Sale (P/S) ratio is 26.13. Its current Enterprise Value per Revenue stands at 43.346 whereas that against EBITDA is -0.9.
Stock Price History:
The Beta on a monthly basis for OTLK is 0.53, which has changed by -0.8883019 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, OTLK has reached a high of $8.32, while it has fallen to a 52-week low of $0.79. The 50-Day Moving Average of the stock is -55.31%, while the 200-Day Moving Average is calculated to be -53.35%.
Shares Statistics:
Over the past 3-months, OTLK traded about 2.95M shares per day on average, while over the past 10 days, OTLK traded about 12906090 shares per day. A total of 43.48M shares are outstanding, with a floating share count of 28.28M. Insiders hold about 36.34% of the company’s shares, while institutions hold 20.56% stake in the company. Shares short for OTLK as of 1755216000 were 2915338 with a Short Ratio of 0.99, compared to 1752537600 on 2023374. Therefore, it implies a Short% of Shares Outstanding of 2915338 and a Short% of Float of 7.969999999999999.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 3.0 analysts currently analyzing and rating the stock of Outlook Therapeutics Inc (OTLK).The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.09 and low estimates of -$0.42.
Analysts are recommending an EPS of between -$1.72 and -$1.89 for the fiscal current year, implying an average EPS of -$1.81. EPS for the following year is -$1.17, with 3.0 analysts recommending between -$0.28 and -$1.67.
Revenue Estimates
For the next quarter, 3 analysts are estimating revenue of $4.4M. There is a high estimate of $5M for the next quarter, whereas the lowest estimate is $3.8M.
Based on 5 analysts’ estimates, the company’s revenue will be $27.8M in the next fiscal year. The high estimate is $51M and the low estimate is $15.92M.
